Background: The aim of this study was to compare the outcomes of
vaginal hysterectomy with McCall culdoplasty and transvaginal mesh surgery in the
management of female pelvic organ prolapse. Methods: We compared
anatomical and functional outcomes who underwent vaginal hysterectomy with McCall
culdoplasty or transvaginal mesh surgery for anterior and apical vaginal prolapse
at a single tertiary center from January 2009 to December 2016. Anatomical
outcome was measured by POP-Q stage and functional outcomes were measured using
three questionnaires: the Pelvic Floor Distress Inventory (PFDI-20), the Pelvic
Floor Impact Questionnaire (PFIQ-7), and the Pelvic Organ Prolapse/Urinary
Incontinence Sexual Questionnaire (PISQ-12). Surgical treatment was done with
POP-Q stage
The prevalence of pelvic organ prolapse (POP) is increasing because of the increase in the elderly female population. POP is the abnormal descent of pelvic organs [1] and its overall prevalence currently ranges from 3 to 50% [2, 3]. One of the surgical treatments for POP is transvaginal mesh surgery and this has been widely utilized due to the relatively short operating time and the less invasive surgical approach [4, 5]. However, during the last decade the US Food and Drug Administration (FDA) has issued warnings regarding the safety and efficacy of synthetic meshes because of the high occurrence of late complications. These include vaginal erosion, dyspareunia, mesh exposure, and postoperative stress urinary incontinence [6]. In the Cochrane library, the recurrence rate was less likely with transvaginal mesh surgery compared to vaginal hysterectomy (RR 0.71, 95% CI 0.52 to 0.96) [7]. In this study, we compared the anatomical and functional outcomes between transvaginal mesh surgery and vaginal hysterectomy with McCall culdoplasty in POP patients.
All patients were assessed as anterior and/or apical prolapse POP-Q (Pelvic
Organ Prolapse Quantification System, International Continence Society) stage
All patients had follow-up at one month, 6 months, one year, and each year thereafter following surgery. At each visit, all patients were examined vaginally by the POP-Q system. Postopertative strees urinary incontinence (POSUI) is a de novo SUI that newly occured after surgery. If urine leakage is present in a situation where abdominal pressure increases such as coughing or laughing, and positive for cough stress test, it is diagnosed as POSUI. Urgency urinary incontinence(UUI) was diagnosed with symptoms of urgency and urinary leakage. Overactive bladder(OAB) was diagnosed with urgency, frequency, and nocturia with or without urine leakage. Also, the urine analysis did not show infection and postvoid residual urine volume (PVR) was normal range. If the postoperative POP-Q stage was greater than II based on the most dependent point and occurrence at the primary site or at a new location, it was defined as a recurrence. This study was approved by the Institutional Review Board of Human Research for our institution, and informed consent was obtained from all participants (Chonnam National University Hospital IRB-2019-306).
Statistical analysis was performed with SPSS 20.0 for Windows (SPSS, Inc., Chicago, IL, USA). Fisher’s exact test was used to compare the qualitative variables. Paired sample t-test was used for intragroup comparison. Chi-square test was used to compare quantitative variables between two groups. A P-value of less than 0.05 was considered statistically significant.
We reviewed the functional and anatomical outcomes of 154 women with symptomatic POP who underwent transvaginal mesh surgeries or vaginal hysterectomy with McCall culdoplasty at a single tertiary center between January 2009 and December 2016. A total of 74 patients underwent transvaginal mesh surgery with partially absorbable mesh (Seratom®), while 80 patients underwent vaginal hysterectomy with McCall culdoplasty and anterior and posterior colporrhaphy. The total follow-up duration was 2 years for each surgical group. No significant differences were detected between the two groups for mean age, parity, mean menopausal age, and the duration of pelvic organ prolapse before surgery (Table 1). In the transvaginal mesh group, the procedures in 4 patients were conducted with transobturator tape (TOT) due to stress urinary incontinence (SUI). In the vaginal hysterectomy with McCall culdoplasty group, 9 patients underwent TOT procedures due to SUI. The mean operative time was not significantly different between the two groups. Table 2 shows the distribution of POP stages in the study population. The majority of patients were POP-Q stage III (83.7% and 77.5%, respectively, in the transvaginal mesh group and the vaginal hysterectomy with McCall culdoplasty group), and in the majority of patients the anterior compartment was prolapsed (82.4% and 78.7%, respectively, in the transvaginal mesh group and the vaginal hysterectomy with McCall culdoplasty group).
Transvaginal mesh operation (n = 74) | Vaginal hysterectomy with McCall culdoplasty (n = 80) | P | |
Age (years)+ | 67.7 |
66.0 |
0.963 |
Parity | 3.33 |
3.30 |
0.980 |
BMI (kg/m |
24.8 |
23.96 |
0.859 |
Menopause age | 49.24 |
48.0 |
0.622 |
Operation time | 66.93 |
67.59 |
0.236 |
Hospital days | 7.66 |
6.69 |
0.009 |
Duration of pelvic organ prolapse (month) | 32.43 |
54.30 |
0.045 |
Diabetes | 10 (13.5%) | 18 (22.5%) | 0.149 |
Hypertension | 34 (45.9%) | 59 (73.8%) | 0.010 |
Data are presented as Mean |
Transvaginal mesh operation (n = 74) | Vaginal hysterectomy with McCall culdoplasty (n = 80) | P | |
POP-Q stage | 0.416 | ||
III | 62 (83.7%) | 62 (77.5%) | |
IV | 12 (16.3%) | 18 (22.5%) | |
Type of prolapse | 0.574 | ||
Anterior compartment | 61 (82.4%) | 63 (78.7%) | |
Apical compartment | 13 (17.6%) | 17 (21.3%) |
Postoperative stress urinary incontinence (POSUI), urgency urinary incontinence (UUI), and recurrence were not statistically different between the groups (Table 3). Surgical outcomes were similar between the two groups. However, at all follow-up periods the postoperative total vaginal length (TVL) was longer in the transvaginal mesh group than in the vaginal hysterectomy with McCall culdoplasty group (Table 4). A total of 6 patients experienced recurrence following transvaginal mesh surgery, while two patients had a recurrence after vaginal hysterectomy with McCall culdoplasty. In the transvaginal mesh group with recurrence, one patient underwent a vaginal hysterectomy with anterior and posterior coloporrhaphy, one underwent abdominal hysterectomy with colposacropexy, and 4 patients were followed-up without surgery. In the vaginal hysterectomy with McCall culdoplasty group, two patients with recurrence were followed-up without surgery. The quality-of-life questionnaire after one-year of follow-up showed continued improvement in both groups, but without statistically significant differences (Table 5).
Transvaginal mesh operation (n = 74) | Vaginal hysterectomy with McCall culdoplasty (n = 80) | P | |
Recurrence | 6 (12.3%) | 2 (2.5%) | 0.155 |
POSUI (Postop stress incontenence) | 13 (17.5%) | 18 (22.5%) | 0.651 |
Urgency urinary incontinence | 7 (9.4%) | 7 (8.7%) | 0.48 |
Overactive bladder | 3 (4.0%) | 8 (10.0%) | 0.147 |
Urinary tract infection | 0 (0%) | 2 (2.5%) | 0.21 |
Bladder injury | 0 (0%) | 0 (0%) | 0.49 |
Data are presented as n (%). |
Preoperative | postop 1 month | postop 6 months | postop 12 months | postop 24 months | |||||||||||
Group 1 (n = 74) | Group 2 (n = 80) | P | Group 1 (n = 74) | Group 2 (n = 80) | P | Group 1 (n = 74) | Group 2 (n = 80) | P | Group 1 (n = 74) | Group 2 (n = 80) | P | Group 1 (n = 74) | Group 2 (n = 80) | P | |
Point Aa (cm) | 2.5 |
2.6 |
0.29 | -2.3 |
-2.7 |
-2.1 |
-2.3 |
0.05 | -2.1 |
-2.1 |
0.15 | -2.1 |
-2.2 |
0.243 | |
Point Ba (cm) | 3.6 |
3.38 |
0.22 | -2.3 |
-2.7 |
-2.1 |
-2.3 |
0.138 | -2.1 |
-2.1 |
0.1 | -2.0 |
-2.2 |
0.26 | |
Point C (cm) | 2.0 |
1.78 |
0.12 | -6.2 |
-6.8 |
0.001 | -5.3 |
-6.4 |
-5.8 |
-5.5 |
0.378 | -5.7 |
-6.1 |
0.167 | |
Total vaginal length (cm) | 6.9 |
7.0 |
0.58 | 7.5 |
7.0 |
0.06 | 7.1 |
6.8 |
0.283 | 7.3 |
6.8 |
0.45 | 7.2 |
6.6 |
0.85 |
Genital hiatus (cm) | 4.6 |
4.0 |
0.04 | 3.7 |
2.9 |
3.7 |
2.8 |
0.17 | 3.5 |
3.0 |
3.5 |
3.0 |
0.01 | ||
Data are presented as Mean Group 1: Transvaginal mesh operation. Group 2: Vaginal hysterectomy with McCall culdoplasty. |
Preoperative | Postoperative | ||||||
Group 1 (n = 74) | Group 2 (n = 80) | P | Group 1 (n = 74) | Group 2 (n = 80) | P | ||
PFDI-20 | 141.5 |
146.7 |
0.311 | 110.0 |
106.4 |
0.213 | |
POPDI-6 | 58.6 |
59.0 |
0.210 | 33.2 |
31.9 |
0.325 | |
CRADI-8 | 43.2 |
47.5 |
0.415 | 37.2 |
39.0 |
0.131 | |
UDI-6 | 49.4 |
47.5 |
0.324 | 36.1 |
27.0 |
0.102 | |
PFIQ-7 | 114.2 |
114.5 |
0.217 | 31.4 |
37.5 |
0.041 | |
POPIQ-7 | 43.1 |
41.3 |
0.153 | 11.2 |
13.6 |
0.234 | |
CRAIQ-7 | 33.1 |
31.1 |
0.632 | 11.1 |
12.6 |
0.221 | |
UIQ-7 | 33.5 |
40.3 |
0.113 | 13.1 |
11.1 |
0.351 | |
PISQ-12 | 13.1 |
12.8 |
0.342 | 8.5 |
9.3 |
0.081 | |
Data are presented as Mean CRADI, Colorectal-Anal Distress Inventory; CRAIQ, Colorectal-Anal Impact Questionnaire; PFDI, Pelvic Floor Distress Inventory; PFIQ, Pelvic Floor Impact Questionnaire; PISQ, Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire; POPDI, Pelvic Organ Prolapse Distress Inventory; POPIQ, Pelvic Organ Prolapse Impact Questionnaire; UDI, Urogenital Distress Inventory; UIQ, Urinary Incontinence Questionnaire. Group 1: Transvaginal mesh operation group, Group 2: Vaginal hysterectomy with McCall culdoplasty group. |
As the adult population grows older, the prevalence of POP has gradually increased [3, 10]. If not properly treated, problems can arise such as urinary disorders, sexual disorders, and frequent urogenital infections. For these reasons, many types of surgery have been performed to treat POP. However, a high rate of recurrence was reported with earlier POP surgeries [3]. Therefore, surgery using synthetic mesh has been widely used to treat POP and reduce the recurrence rate [7, 11]. However, the use of synthetic mesh is associated with a high incidence of complications, such as mesh exposure, vaginal erosion, de novo SUI, and bladder injury during surgery. For these reasons, the FDA has warned against the use of synthetic mesh in the treatment of POP [6].
Many studies have compared the anatomical outcomes from vaginal mesh surgery and native tissue repair, but few have evaluated the functional outcomes. In this study, the anatomical and functional outcomes were compared between two groups of POP patients treated at a single institution: those who underwent transvaginal mesh surgery and those who underwent vaginal hysterectomy with McCall culdoplasty. No differences were found between the two groups for anatomical outcomes, except with regards to total vaginal length on the POP-Q stage. In the transvaginal mesh group, total vaginal length was longer than in the vaginal hysterectomy with McCall culdoplasty group. Presumably, this was due to differences in the fixation point for each type of surgery. In transvaginal mesh surgery, the vaginal apex fixation level is at the ischial spine, which is more proximal than the fixation point in vaginal hysterectomy with McCall culdoplasty [8, 9, 10]. This may be related to TVL and sexual function. However, there were no statistical differences between the groups in the PISQ-12. Furthermore, this study showed no statistical differences for the recurrence and reoperation rates between the transvaginal mesh surgery and vaginal hysterectomy with McCall culdoplasty groups. Complications, such as POSUI, UUI, recurrences, and bladder injuries were also not significantly different between the two groups.
Many studies have reported techniques to treat POP. Some studies have reported a maximum recurrence rate of 50% when native tissue repair was performed [2, 3]. Others have reported a higher success rate and lower recurrence or re-operation rate with vaginal mesh surgery compared to native tissue repair [12, 13]. Another study reported that de novo SUI was lower in the anterior colporrhaphy group (1.4%, 1/68 patients) compared to the mesh group (8.5%, 6/70 patients). However, the results of another study showed that the recurrence rate for mesh surgery was lower than that of native tissue repair [14]. Another study reported that sexual function may be problematic with vaginal hysterectomy [15].
However, some studies have reported good anatomical and functional outcomes following McCall culdoplasty with transvaginal hysterectomy [16, 17]. Paz-levy et al. reported a high success rate with native tissue repair in anterior compartment-prolapsed patients and showed good results for anatomical and functional outcomes and quality of life [18]. Pieternel et al. reported no significant anatomical or composite benefit for partially absorbable mesh over native tissue repair [19].
In the present study, no significant differences in anatomical and functional outcomes, operative time, or complications were observed between the two surgical groups. While the US FDA has warned against the use of synthetic mesh, surgery using native tissue is not inferior to transvaginal mesh surgery. The limitations of this study include its retrospective design, small sample size and short follow-up duration. And we only considered anatominal outcomes when diagnosing recurrence without considering patient’s symptomes. Moreover, partially absorbable mesh was investigated and not other types of mesh. However, the strengths of the study are that all surgery was performed by one surgeon, functional and anatomical outcomes were compared between the two types of surgery.
In the advanced stages of anterior and apical compartment pelvic organ prolapse, vaginal hysterectomy with McCall culdoplasty and transvaginal mesh surgery showed no differences in anatomical and functional outcomes. Therefore, although transvaginal mesh has been removed from the market in many countries the hysterectomy and McCall culdoplasty remains a viable option.
CHK designed the research study. HBC and MKC performed the research. All authors contributed to editorial changes in the manuscript. All authors read and approve the final manuscript.
This study was approved by the Institutional Review Board of Human Research for our institution and informed consent was obtained from all participants (CNUH IRB-2019-306).
We would like to express our gratitude to all those who helped us during the writing of this manuscript.
This research received no external funding.
The authors declare no conflict of interest.